BioTelemetry (BEAT) Downgraded by Zacks Investment Research – Rockland Register
BioTelemetry (BEAT) Downgraded by Zacks Investment Research Rockland Register
Zacks Investment Research downgraded shares of BioTelemetry (NASDAQ:BEAT) from a buy rating to a hold rating in a report issued on Friday, Zacks.com …
Source: Investment New Feed